Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine and Azithromycine in COVID-19 Patients With Hematological Malignancies
NCT04392128Phase 2Withdrawn
- Sponsor
- Institut de cancérologie Strasbourg Europe
- Start
- Sep 2020
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydroxychloroquine, azithromycin in coronavirus disease 2019 (COVID-19), sponsored by Institut de cancérologie Strasbourg Europe. Planned start Sep 2020; status: withdrawn.
02
Drugs
hydroxychloroquineazithromycin
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04392128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04392128.